NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™

Orlando, FL US
March 22, 2018 to March 24, 2018

The NCCN Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ attracts more than 1,600 registrants from across the United States and the globe including oncologists (in both community and academic settings), oncology fellows, nurses, pharmacists, and other health care professionals involved in the care of patients with cancer. Respected opinion leaders present the latest cancer therapies and provide updates on selected NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), the data upon which the NCCN Guidelines® are based, and quality initiatives in oncology. Topics change annually but focus on the major cancers and supportive care areas.

Agenda

Fees

Target Audience

This educational program is designed to meet the educational needs of physicians (medical, surgical, and radiation oncologists); nurses; physician assistants; pharmacists; case managers; cancer registrars; and other health care professionals who manage patients with cancer.

Learning Objectives

Following this program, participants should be able to:

  • Summarize key updates of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and as appropriate integrate these strategies into the management of patients with acute lymphoblastic leukemia, acute myeloid leukemia, bladder cancer, breast cancer, chronic myeloid leukemia, central nervous system cancers, colon and rectal cancers, ovarian cancer, head and neck cancers, hepatocellular carcinoma, human immunodeficiency virus, kidney cancer, lung cancer, melanoma, multiple myeloma, and prostate cancer
  • Review issues relevant to patients receiving CAR T-cell therapy, immunotherapy, patients being managed for venous thromboembolism, and those receiving supportive care for adult cancer pain and palliative care and incorporate appropriate strategies into clinical practice
  • Evaluate current therapeutic advances and emerging clinical trials data and apply relevant findings into the management of patients with cancer.

A detailed list of learning objectives by session topic is available here.

Additional information
Supporters: 

This activity is supported by an educational grant from

  • Astellas
  • AstraZeneca
  • Biocompatibles, Inc. (BTG)
  • Celgene Corporation
  • Genentech
  • Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
  • Jazz Pharmaceuticals, Inc.
  • Lilly
  • Novartis
  • Pfizer
  • Prometheus Laboratories Inc.
  • Sanofi Genzyme
  • Taiho Oncology

Supported by an independent educational grant from AbbVie; Boehringer Ingelheim Pharmaceuticals, Inc.; Incyte; and Merck & Co., Inc.

Supported by an unrestricted educational grant from Gilead Sciences, Medical Affairs

Supported by educational funding provided by Amgen

Course summary
Available credit: 
  • 17.25 ABIM MOC
  • 17.25 AMA PRA Category 1 Credit™
  • 17.25 ANCC contact hours
  • 17.25 CCM clock hours
  • 17.25 NCRA CE hours
  • 17.25 Participation
  • 10.75 Category A
Course opens: 
03/19/2018
Course expires: 
08/17/2018
Event starts: 
03/22/2018 - 8:00am
Event ends: 
03/24/2018 - 3:00pm
Cost:
$0.00
Rosen Shingle Creek
9939 Universal Blvd
Orlando, FL 32819
United States

All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

Physicians
National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NCCN designates this live activity for a maximum of 17.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17.25 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Aggregated participant data will be shared with the commercial supporters of this activity.

American Board of Medical Specialties Maintenance of Certification
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Maintenance of Certification (“MOC”) Activities through the ABMS Continuing Certification Directory, NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) by the following ABMS Member Boards:

MOC Part II CME Activity
Pathology
Radiology
Urology

Note: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement (only). Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 17.25 hours of Category 1 credit for completing this activity.

Nurses
National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

NCCN designates this educational activity for a maximum of 17.25 contact hours.

Pharmacists

National Comprehensive Cancer Network is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

NCCN designates this knowledge-based continuing education activity for 17.25 contact hours (1.725 CEUs) of continuing education credit. UANs: 0836-0000-18-034-L01-P to 0836-0000-18-054-L01-P

Case Managers
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. The course is approved for 17.25 CE contact hours. Activity Code: C00031308; Approval Number: 180000985

Cancer Registrars
This program supports 17.25 CE hours of which 10.75 CE hours meet the Category A requirement and has been assigned the following event number: 2018-077.

Available Credit

  • 17.25 ABIM MOC
  • 17.25 AMA PRA Category 1 Credit™
  • 17.25 ANCC contact hours
  • 17.25 CCM clock hours
  • 17.25 NCRA CE hours
  • 17.25 Participation
  • 10.75 Category A

Accreditation Period

Course opens: 
03/19/2018
Course expires: 
08/17/2018

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection
  • Adobe Reader or other PDF reader software for certificate viewing/printing